How big is the China Cardiovascular Devices Market?

The China Cardiovascular Devices Market size is expected to reach USD 2.99 billion in 2024 and grow at a CAGR of 5.79% to reach USD 3.97 billion by 2029. Read More

What is the current China Cardiovascular Devices Market size?

In 2024, the China Cardiovascular Devices Market size is expected to reach USD 2.99 billion. Read More

Who are the key players in China Cardiovascular Devices Market?

Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Lepu Medical Technology(Beijing)Co.,Ltd. and Terumo Corporation are the major companies operating in the China Cardiovascular Devices Market. Read More

What years does this China Cardiovascular Devices Market cover, and what was the market size in 2023?

In 2023, the China Cardiovascular Devices Market size was estimated at USD 2.83 billion. The report covers the China Cardiovascular Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the China Cardiovascular Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

China Cardiovascular Devices Market Share

Statistics for the 2023 & 2024 China Cardiovascular Devices market share, created by Mordor Intelligence™ Industry Reports. China Cardiovascular Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of China Cardiovascular Devices Industry

The competitive landscape of the China Cardiovascular devices market covers the business overview, financials, products, and strategies followed by major companies. The cardiovascular devices market in China is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the Key companies which are currently dominating the market are Abbott Laboratories, Boston Scientific Corporation, Mindray Medical International Limited, Edwards Lifesciences, WL Gore & Associates Inc., Medtronic PLC, Lepu Medical Technology (Beijing) Co. Ltd, Terumo Corporation, and Microport Scientific Corporation, among others.